Home
Adage Capital Management reported a 3.9% stake in Aligos Therapeutics ALGS · 210,000 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 3.9%
- Last report
- 9.38% · filed 25/02/12
- Shares held
- 210,000 sh
- Class
- Voting Common Stock, par value $0.0001 per share
- Holder
- Adage Capital Management
- Event date
- 25/06/30
- Filed
- 25/08/12
3.9% stake · below 5%
- Stake
- 3.9%
- Last report
- 9.38%
- Since last report
- −5.5pp
Aligos Therapeutics trades, last 26 weeks
What else happened in Aligos Therapeutics around then
Filed or reported within 30 days of the trade day · 25/05/31~25/07/30Adage Capital Management's other 5% stake reports
- Adage Capital Management
5% stakeForefront Tech Holdings Acquisition
5% stakeForefront Tech Holdings Acquisition
FTHA
9% stake
900,000 sh
9% stake
Filed 08/12
- Adage Capital Management
5% stakeEquillium
5% stakeEquillium
EQ
7.25% stake
4,832,767 sh
7.25% stake
Filed 08/12
- Adage Capital Management
5% stakeEnergy Transition Special Opportunities
5% stakeEnergy Transition Special Opportunities
ETSS
9% stake
1,350,000 sh
9% stake
Filed 08/12
- Adage Capital Management
5% stakeCybin
5% stakeCybin
HELP
5.29% stake
3,289,250 sh
5.29% stake
Filed 08/12
- Adage Capital Management
5% stakeYorkville International Capital
5% stakeYorkville International Capital
YICC
7.83% stake
1,800,000 sh
7.83% stake
Filed 08/12
